Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization
Release time:2023-12-27 | Click rate:
From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuberculosis prevention and control, was held in Paris, France. Zhifei was invited to attend the meeting. Pu Jiang, the company's vice president, delivered a themed report on "Research on the Clinical Safety and Effectiveness of Vaccae" and introduced the use of Mycobacterium Vaccae (trade name: "Vaccae") to prevent tuberculosis in people with latent tuberculosis infection, and shared domestic experience in tuberculosis prevention and control. As the world's first successfully developed immune preparation to prevent tuberculosis in people with latent tuberculosis infection since the introduction of the BCG vaccine over a century ago, "Vaccae" has attracted widespread attention from participants at the conference.
On November 20th and 21st, the team visited well-known international organizations such as World Health Organization (WHO), the Global Fund, and the STOP TB Partnership in Geneva, Switzerland, to discuss the company's full range of products. They conducted in-depth exchanges on the research and development progress of product development and international cooperation to promote the company's internationalization progress.
At present, Zhifei has carried out market registration of tuberculosis products in Indonesia, Pakistan, Uzbekistan and other countries, and will launch a series of international clinical studies.
Zhifei will continue to fulfill its mission of "Safeguarding human health, by preventing the unseen and treating the ailing", strengthen exchanges and cooperation with international organizations, continue to expand international market, and make positive contributions to the prevention and control of human diseases.